Navigation Links
FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
Date:11/21/2008

RARITAN, N.J., Nov. 21 /PRNewswire/ -- Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option. Today, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD), announced that the U.S. Food and Drug Administration (FDA) approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults 18 years of age or older.

Tapentadol is a new centrally acting oral analgesic. It has two mechanisms of action, combining mu-opioid receptor agonism and norepinephrine reuptake inhibition.

Tapentadol tablets have been approved in 50 mg, 75 mg and 100 mg doses.

The approval was based on data from clinical studies involving more than 2,100 patients. The studies, which were presented at the 27th Annual Scientific Meeting of the American Pain Society earlier this year, showed that tapentadol provided significant relief of moderate to severe acute pain compared to placebo.

Following today's FDA approval, and as per Federal regulation for all controlled substances, tapentadol will be reviewed by the U.S. Drug Enforcement Agency for scheduling, and it cannot be sold until it receives a scheduling classification.

A trade name for tapentadol has not yet been determined.

"We are pleased with the FDA's approval today. Tapentadol represents a new treatment option in pain management, and I am excited that we are able to bring this new choice to patients who are suffering from pain," said Joanne Waldstreicher, M.D., Global Head, Research and Development for CNS/Internal Medicine, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

More than 25 million Americans experience acute pain each year as a result of injuries or surgery, and it is the most common reason people seek medical attenti
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015 STAAR Surgical Company (NASDAQ: ... of implantable lenses and delivery systems for the eye, ... J. Steven Roush , CPA to the Company,s ... on STAAR,s Board to seven.Mr. Roush brings an important ... gained over a 39 year tenure as a Partner ...
(Date:4/21/2015)... and CAMBRIDGE, Mass. , April ... Tokyo : 4503) and Potenza Therapeutics, Inc., ... programs, today announced an exclusive research and development ... advance a portfolio consisting of programs with novel ... signals and regulatory T cells. The agreement includes ...
(Date:4/21/2015)... , April 21, 2015  EBD Group, organizer ... announced Medtech Partnering Forum 2015 , a new ... event, held May 28–29 in Tokyo ... conference in Japan . ... the rapidly changing medical technology industry in ...
Breaking Medicine Technology:J. Steven Roush, CPA Appointed to STAAR Surgical Board of Directors 2J. Steven Roush, CPA Appointed to STAAR Surgical Board of Directors 3Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 2Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 2Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 4
... April 23, 2012 Medela convened the 7th ... on April 20-21, 2012. The annual event, attended ... lactation consultants, highlighted the latest insights into breastfeeding ... supporting breastfeeding women and their families through research ...
... SAN DIEGO, April 23, 2012  Trovagene, Inc. (Pink ... announced the appointment of Keith McCormick as head ... McCormick brings extensive pharmaceutical and diagnostic sales, ... as senior director of sales operations at bioTheranostics, ...
Cached Medicine Technology:Latest Findings in Breastfeeding Science Presented at Medela's 7th International Breastfeeding and Lactation Symposium 2Latest Findings in Breastfeeding Science Presented at Medela's 7th International Breastfeeding and Lactation Symposium 3Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations 2Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations 3
(Date:4/21/2015)... Palliative care and accountable care organizations ... for the benefit of patients—and both save money. A ... equation of ACOs appears in the current issue of ... of Managed Care . , The authors, Amy S. ... both at the Icahn School of Medicine, Mount Sinai, ...
(Date:4/21/2015)... HAMMOND, La. (PRWEB) April 22, 2015 ... many of them aren’t aware of many products that ... “Most people don’t realize the dangers of physical inactivity ... man-made toxins that exist. Furthermore, smokers ... is.” , Inspired by his own success in losing ...
(Date:4/21/2015)... Lighthouse Point, FL (PRWEB) April 22, 2015 ... will join the nation’s efforts to raise awareness on ... DMCC University . DMCC is helping to promote the ... education. , For over a decade, DMCC has ... informative seminars. DMCC University incorporates their free educational materials ...
(Date:4/21/2015)... 2015 NAPW honors ... a 2015-2016 inductee into the NAPW VIP Woman of ... distinction for leadership in business. With more than 700,000 ... the nation's leading networking organization exclusively for professional women. ... group of professional women,” said NAPW President Star Jones. ...
(Date:4/21/2015)... Registered Dental Hygienists in Alternative ... specialize in treating patients with special needs, including ... conditions limit their abilities to access quality preventive ... reach out to populations who have difficulty accessing ... RDHAP provides patients the same type of professional ...
Breaking Medicine News(10 mins):Health News:Palliative Care and ACOs: A Perfect Fit 2Health News:New Book shares ‘A Doctor’s Prescription for Longevity and Survival’ 2Health News:New Book shares ‘A Doctor’s Prescription for Longevity and Survival’ 3Health News:DMCC Releases Financial Education Website to Support Financial Literacy Month 2Health News:National Association of Professional Women Announces Leslie Bender, ARS’s Vice President of Risk Management and General Counsel, a 2015 Professional Woman of the Year 2Health News:AB 502 to be heard April 28 in Assembly Health Committee: Send letters of support now 2Health News:AB 502 to be heard April 28 in Assembly Health Committee: Send letters of support now 3
... on the rise. Usually patients underwent a minimally invasive procedure ... from neck arteries. //But studies show that this ha unexpected ... of the study were presented at a medical conference in ... the procedure may allow many elderly people to continue to ...
... Disorder (ADHD) affects about two and a-half million children ... medication but FDA says that strong warnings are required ... // But parents are wondering if there will ever ... Bowens has found something that they say has worked ...
... the ubiquitous crossword puzzles, is all set to conquer Indian ... this popular puzzle to its subscribers on their handsets. // ... any mobile phone in India," said an official of Bharti ... services. ,"To download the popular Japanese logic puzzle, ...
... after taking 13 ecstasy pills to impress his friends at a ... later Michael suffered from mild epilepsy at his pal’s place. He ... friends tried to revive him but in vain. He was taken ... The young boy really did not understand what he was doing ...
... rock band Primal Scream has had a fascinating journey and as ... studio album, Riot City Blues, it is time for introspection for ... in the early 90s. // ,But after that there was ... drugs. It was then that the "heroin hell" kicked in and ...
... was inspired to become a nurse after she saw how the military ... down the line, she heads the US Army Nurse Corps. // ... I had a big brother who was injured in Vietnam and the ... I was going to be a nurse so I could help someone ...
Cached Medicine News:Health News:Neck Artery Treatment Apart From Clearing Plaques Boosts Memory 2Health News:Teenagers Get Hooked To Ecstasy 2Health News:Joining The Military 'My Best Move' - US Army Nursing Chief 2
... is a cervical plate system for ... The implant provides for the immobilization ... bone transplant has consolidated. Optimized stabilization ... bicortical fixation. Maximum purchase also with ...
... plate acc. to Matzen is used for ... (HWS) with the exception of C0-C2. The ... fusion length until the bone transplant has ... the vertebral bodies, if possible along the ...
... Ant-Cer is the newest addition ... anterior cervical plates. Ant-Cer addresses ... stabilization of the cervical spine. ... adjust settling to fit patients' ...
... cervical plate system is the lowest profile ... includes an integrated lock mechanism, which is ... screws. Surgeons appreciate the narrow width, which ... required. The system also offers easy to ...
Medicine Products: